At a glance
ClinicalIndex Comparison RecordN/ACompleted· 185 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Data Collection: Post Study Treatment Anticancer Therapy From All Randomized Patients Involved in IMELDA MO22223
In Brief
An observational study evaluating No Intervention for Breast Cancer. Completed, enrolled 185 participants across 32 sites in 6 countries.
Detailed Summary
This study aims to understand better the effective results from the IMELDA MO22223 P-trial (NCT00929240) and see if the anti-cancer therapies given during its follow-up time after study treatments were terminated possibly had an effect on efficacy results.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesBrazil, France, India, Italy, Spain, Turkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartApr 2015
Primary CompletionJan 2016
TodayJul 2026
First PostedMar 9, 2015
Enrollment StartApr 30, 2015
Primary CompletionJan 22, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 11.3 years ago
Interventions
No Interventionother
No intervention administered in this study.